Trango Medical Competitors and Similar CompaniesClear all

Trango Medical's competitors and similar companies include Southern Prosthetic Supplies, Richard Wolf, Midmark and Zhejiang Gongdong Medical Technology.

	Trango Medical Trango Medical is a medical device company.	Southern Prosthetic Supplies Southern Prosthetic Supplies (SPS) is a company that distributes orthotic and prosthetic products.	Richard Wolf Richard Wolf is a supplier of products and solutions for endoscopy and extracorporeal shock wave treatment.	Midmark Midmark is a company that manufactures and supplies medical, dental, and veterinary equipment.	Zhejiang Gongdong Medical Technology Zhejiang Gongdong Medical Technology is a manufacturer and supplier of medical devices and supplies.
Founding Date	Founding Date 1991	Founding Date 1951	Founding Date 1906	Founding Date 1915	Founding Date 1985
Type	Type Private	Type Subsidiary	Type Private	Type Private	Type Public
Tags	Tags Healthcare medical devices	Tags Retail distribution medical devices	Tags Healthcare medical devices	Tags Healthcare dental ecommerce medical devices veterinary	Tags Healthcare medical devices
Locations	Locations Hoorn, NL HQ	Locations Alpharetta, US HQ Fresno, US	Locations Knittlingen, DE HQ Wien, AT Gent, BE Sao Paulo, BR Beijing, CN Shanghai, CN Reims, FR see more	Locations Versailles, US HQ Brisbane City, AU Melbourne, AU Perth, AU Sydney, AU Bruxelles, BE São Paulo, BR see more	Locations Taizhou, CN HQ Riverside, US
Employees	Employees 4	Employees 1981% increase	Employees 1,800	Employees 2,200	Employees 1,693
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €249.9m (FY, 2021)	Revenue (est.) $717m (FY, 2022)	Revenue (est.) ¥1.1b (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods €70.1m (FY, 2021)	Cost of goods N/A	Cost of goods ¥749.5m (FY, 2024)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit €179.7m (FY, 2021)	Gross profit N/A	Gross profit ¥352.8m (FY, 2024)
Net income	Net income N/A	Net income N/A	Net income €4.1m (FY, 2021)	Net income N/A	Net income ¥171.5m (FY, 2024)